Pall Corporation to Acquire California Firm

, the Port Washington-based filtration equipment company, says it will acquire ForteBio, a California-based provider of advanced analytical systems that accelerate the discovery and development of biotech drugs.

Terms of the deal were not disclosed.

The move is expected to extend Pall’s position in the more than $1 billion biopharmaceuticals process monitoring market and in the protein research market, according to a press release issued on Monday.

“BioPharmaceuticals continues to be the engine of our Life Sciences business and an important long-term growth accelerator," said Larry Kingsley, Pall CEO and president, in a statement. "The addition of ForteBio’s platforms into our business reinforces Pall’s commitment to helping customers get their life-changing products to market safely and on time.”

According to Pall, ForteBio’s portfolio of analytical solutions enables researchers to “measure proteins in real time without the aid of fluorescent, radio or calorimetric labels or markers that can contaminate samples. This enables significantly easier, faster and better characterization of drug candidates, which can help improve process development and speed time to market.”

The transaction is expected to close by February 2012.